Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

Details Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

2001-05-22

2009-11-17

Anderson, Rebecca L (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S235800, C514S236800, C514S254020, C514S314000, C514S326000, C514S365000, C544S121000, C544S129000, C544S133000, C544S359000, C544S367000, C546S135000, C546S187000, C548S185000, C548S187000, C548S184000

Reexamination Certificate

active

07618961

ABSTRACT:
The present invention relates to compounds with the formula (II) and also to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-β-hydroxysteroid dehydrogenase type 1 enzyme.

REFERENCES:
patent: 2362087 (1944-11-01), Newbery
patent: 2611770 (1952-09-01), Smith, Jr.
patent: 4254260 (1981-03-01), Takaya et al.
patent: 5403857 (1995-04-01), Edwards et al.
patent: 5594021 (1997-01-01), Chan et al.
patent: 5783597 (1998-07-01), Beers et al.
patent: 5856347 (1999-01-01), Hashiguchi et al.
patent: 5962490 (1999-10-01), Chan et al.
patent: 6030991 (2000-02-01), Chan et al.
patent: 7030135 (2006-04-01), Nilsson et al.
patent: 2003/0130258 (2003-07-01), Kurz et al.
patent: 2003/0130279 (2003-07-01), Kurz et al.
patent: 2003/0130318 (2003-07-01), Barf et al.
patent: 2003/0166689 (2003-09-01), Kurz et al.
patent: 2003/0176476 (2003-09-01), Barf et al.
patent: 2003/0199501 (2003-10-01), Nilsson et al.
patent: 2004/0224996 (2004-11-01), Barf et al.
patent: 2210613 (1998-01-01), None
patent: 2466490 (2003-05-01), None
patent: 0 749 964 (1996-12-01), None
patent: 0 790 057 (1997-08-01), None
patent: 0 819 681 (1998-01-01), None
patent: 1 069 114 (2001-01-01), None
patent: 94.123 (1969-05-01), None
patent: 2 384 498 (1978-10-01), None
patent: 620654 (1940-07-01), None
patent: 822947 (1959-11-01), None
patent: 6610324 (1969-01-01), None
patent: 2001483 (1990-01-01), None
patent: 03173876 (1991-07-01), None
patent: 6-87841 (1994-03-01), None
patent: 6610324 (1967-01-01), None
patent: WO 96/04912 (1996-02-01), None
patent: WO 96/38179 (1996-12-01), None
patent: WO 97/07789 (1997-03-01), None
patent: WO 98/16520 (1998-04-01), None
patent: WO 98/27081 (1998-06-01), None
patent: WO 98/36770 (1998-08-01), None
patent: WO 99/02502 (1999-01-01), None
patent: WO 99/28306 (1999-06-01), None
patent: WO 99/65884 (1999-12-01), None
patent: WO 00/02851 (2000-01-01), None
patent: WO 01/01971 (2001-01-01), None
patent: WO 01/52833 (2001-07-01), None
patent: WO 01/54691 (2001-08-01), None
patent: WO 01/90090 (2001-11-01), None
patent: WO 01/90091 (2001-11-01), None
patent: WO 02/28353 (2002-04-01), None
patent: WO 03/011258 (2003-02-01), None
Database CAS Online on STN, Chem. Abstr., Accession No. 1941:32570, Dansk Tidsskrift for Farmaci (1941), 15, 41-77, abstract only.
Huff, Joel R., “HIV Protease: A Novel Chemotherapeutic Target for AIDS,”Journal of Medicinal Chemistry, vol. 34, No. 8, Aug. 1991, pp. 2305-2314.
Röver, S., et al., “Synthesis and Biochemical Evaluation of N-(4-Phenylthiazol-2-yl)benzenesulfonamides as High-Affinity Inhibitors of Kynurenine 3-Hydroxylase”, J. Med. Chem., 40, pp. 4378-4385 (1997).
Anton-Fox et al., “Pharmacological Studies of the Two New Hypoglycaemic Compounds 4-(3-Methyl-5-oxo-2-pyrazolin-1-hl)benzoic Acid and 1-(Mesitylen-2-sulfonyl)-1H-1,2,4-triazole,” Arzneim.-Forsch./Drug Res 1994, 44(11), No. 7, pp. 821-826.
Merck & Co. Inc., USA, 1999, Monograph No. 4488, “Glybuzole,” CAS Registry No. 1492-02-0.
Merck & Co., Inc., USA, 1999, Monograph No. 9084, “Sulfamethizole,” CAS Registry No. 144-82-1.
Beuchet, Eur. J. Med. Chem., 34(9), p. 773 (1999).
Desai et al., “Sulfonamides. II. Preparation of N1-hetrocyclic substituted sulfonamides from alpha-naphthylamine and evaluation of their antibacterial properties”, J. Indian Chem. Soc. 46(2):115-118, (1969). CAPLUS accession No. 1969:412872, document No. 71:12872.
Desai et al., “Sulfonamides. IV. Some N-6-heterocyclic sulfonamides from 2-paphthylamine as possible antibacterial agents”, J. Indian Chem. Soc. 46(2): 411-414, 1969. Caplus accession No. 1969:449825, document No. 71:49825.
Gagiu et al., “Mitodepressive substances. 6.4-[(Haloacetyl)amino]-N1-$-benzenesulfonamides”, Pharmazie 27(3):166, 1972. CAPLUS accession No. 1972:428762, document No. 77:28762.
DiCarlo et al., “Pentobarbital action on the binding capability of methylenoxytetracycline sulfaethylthiazole, and cyancobalamin with serum macromolecules”, Atti Soc. Ital. Sci. Vet. 20:278-82, 1966, CAPLUS accession No. 1967:4020611, document No. 67:2061.
Chaurasia et al., “Synthesis of some new 2-sulphanilamidothiazoles as potential fungicides”, Agric. Biol. Chem. 45(5): 1129-34, 1981. CAPLUS accession No. 1981-480840, document No. 95-80840.
Chemcats, “5-Thiazolecarboxylic acid, 4-methyl-2-(((4-methylphenyl)sulfonyl)amino)-, ethyl ester,” Phrma Library Collection, (May 14, 2001). Chemcats Accession No. 2001:20962, Order No. NS46076, CAS Registry No. 313230-18-1.
Chemcats, “5-Thiazolecarboxylic acid, 2-(((4-chlorophenyl) sulfonyl)amino)-4-methyl-, ethyl ester,” Pharma Library Collection, (May 14, 2001). Chemicals Accession No. 2001:19109, Order No. NS41693, CAS Registry No. 312915-26-7.
Chemcats, “5-Thiazolecarboxylic acid, 4-methyl-2-(((3-nitrophenyl)sulfonyl)amino)-, ethyl ester,” ChemDiv. Inc. Product Library, (Apr. 26, 2001). Chemcats Accession No. 2001:786400, Order No. 0947-0103. CAS Registry No. 313237-92-2.
Chemcats, “5-Thiazolecarboxylic acid, 4-methyl-2-((phenylsulfonyl)amino)-, ethyl ester,” Pharma Library Collection, (May 14, 2001). Chemcats Accession No. 2001:2446055, Order No. NS44365, CAS Registry No. 313237-91-1.
Chemcats, “5-Thiazolecarboxylic acid, 4-methyl-2-((2-naphthalenylsulfonyl)amino)-, ethyl ester,” Pharma Library Collection, (May 14, 2001). Chemcats Accession No. 2001:19110, Order No. NS41694, CAS Registry No. 312915-27-8.
Chemcats, “5-Thiazolecarboxylic acid, 4-methy1-2-((4-methylphenyl)sulfonyl)amino)-, ethyl ester,” Compounds for Screening, (Jul. 1, 2001). Chemcats Accession No. 2001:1499370, Order No. AG-690/36005052, CAS Registry No. 313230-18-1.
Chemcats, “5-Thiazolecarboxylic acid, 2-(((2-chlorophenyl)sulfonyl)amino)-4-methyl-ethyl ester,” Interbioscreen Compound Library, (Feb. 11, 2002). Chemcats Accession No. 2002:175108, Order No. STOCK2S-28380, CAS Registry No. 378764-18-2.
Chemcats, “5-Thiazolecarboxamide, 4-methyl-N-phenyl-2-((phenylsulfonyl)amino)-,” Interbioscreen Compound Library, (Feb. 11, 2002). Chemcats Accession No. 2002:174900, Order No. STOCK2S-27987, CAS Registry No. 378768-75-3.
Chemcats, “5-Thiazolecarboxamide, 2-(((2,5-dimethylphenyl)sulfonyl)amino)-4-methyl-N-phenyl-,” Interbioscreen Compound Library, (Feb. 11, 2002). Chemcats Accession No. 2002:310940, Order No. STOCK2S-37273, CAS Registry No. 380584-86-1.
Chemcats, “5-Thiazolecarboxamide, 4-methyl-2-(((4-methylphenyl)sulvonyl)amino)-N-phenyl-,” Interbioscreen Compound Library, (Feb. 11, 2002). Chemcats Accession No. 2002:310143, Order No. STOCK2S-35716, CAS Registry No. 380590-91-0.
Chemcats, “5-Thiazolecarboxylic acid, 2-(((2,5-dimethylphenyl)sulfonyl)amino)-4-methyl-, ethyl ester,” Interbioscreen Compound Library, (Feb. 11, 2002). Chemcats Accession No. 2002:312516, Order No. STOCK2S-40385, CAS Registry No. 380878-60-4.
Hökfelt, Bernt “Hypoglycemic Activity in Relation to Chemical Structure of Potential Oral Antidiabetic Substances, I. 1-Sulfonyl-3-alkylureas,”Journal of Medicinal and Pharmaceutical Chemistry, 5(1):231-257 (Jan. 6, 1962) ©American Chemical Society.
Sonlno et al., “Ketoconazole treatment in Cushing's syndrome: experience in 34 patients,”Clinical Endocrinology35:347-352 (1991) ©Blackwell Scientific Publications Ltd.
Verhelst et al., “Use of ketoconazole in the treatment of a virilizing adrenocortical carcinoma,”Acta Endocrinologica121:229-234 (1989) ©Acta Endocrinologica (Copenhagen).
“Analgesic tetrahydrothiazolo[5,4-c]pyridines, Fr. Addn., Addn to FR. 1498465 (1969),” corresponding to FR 6013, (Jul. 1, 1969).
Hisamitsu Pharmaceutical Co: “Preparation of 2-(substituted amino)thiazole derivatives as esterase inhibitor

Affiliated with

Also associated with

Rating

Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4074180